Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Prognostic Value of Follow-Up Mean Pulmonary Arterial Pressure and Pulmonary Vascular Resistance in Patients with Pulmonary Arterial Hypertension Reaching a Low-Risk Profile
Anno:
2024
Background: Hemodynamic variables such as right atrial pressure, cardiac index (CI), stroke volume index (SVI), and mixed venous oxygen saturation have consistently been associated with survival in pulmonary arterial hypertension (PAH). New PAH treatments are, however, able to improve short-term outcome reducing mean pulmonary arterial pressure (mPAP) and pulmonary…
Leggi di più
AN UNUSUAL CASE OF PULMONARY ARTERIAL HYPERTENSION FOLLOWING SURGICAL TREATMENT OF A LUNG ABSCESS IN A PATIENT WITH LATENT SYSTEMIC SCLEROSIS
Anno:
2024
Background: Pulmonary arterial hypertension(PAH) is frequently associated with systemic sclerosis(SS). Nevertheless, little is known about the triggers that may exacerbate PAH in these patients. Case report: A 71-year-old woman, previously diagnosed with Raynaud ‘s Syndrome and without any other significant medical history, was admitted to our Emergency Room due…
Leggi di più
A case of pulmonary hypertension associated with myelofibrosis: therapeutical challenges from acute to chronic setting
Anno:
2024
A 85-year-old female was transferred to our ICCU for acute heart failure from one of our spoke hospitals. The patient had a long history of chronic myelofibrosis, treated with fedratinib as a second-line agent after ruxolitinib failure. During a recent hospital admission, transthoracic echocardiography already showed signs of severe…
Leggi di più
INDIPENDENT PROGNOSTIC VALUE OF SOLUBLE-SUPRESSION OF TUMORIGENICITY (s-ST2) IN PATIENTS AFFECTED BY PULMONARY HYPERTENSION
Anno:
2024
Introduction: According to ESC 2022 guidelines, pulmonary hypertension (PH) is a hemodynamic condition characterized by mean pulmonary arterial pressure>20 mmHg. Pulmonary arterial hypertension (PAH) represents 5% of the PH, with an unfavorable prognosis primarily because of late diagnosis and treatment. In PAH, it is important to evaluate the individual…
Leggi di più
NEW ONSET OF PULMONARY HYPERTENSION IN A PATIENT AFFECTED BY RECURRENT LUNG CANCER
Anno:
2024
39 years old non-smoker female patient came to our observation in July 2023 complaining dyspnea on mild exertion. She had a history of lung adenocarcinoma with epidermal growth factor receptor (EGFR) positive for exon 19 deletion treated with left pneumonectomy and ipsilateral hilar mediastinal lymphadenectomy 5 years earlier, and…
Leggi di più
A 20-YEAR FOLLOW-UP OF SUCCESSFUL SURGICAL MANAGEMENT OF DOUBLE-OUTLET RIGHT VENTRICLE WITH PULMONARY STENOSIS: A CASE REPORT
Anno:
2024
A 25-year-old man, suffering from worsening exertional dyspnea for 4 months, was referred to our Cardiology Unit. The patient was previously diagnosed with a late diagnosis of double outlet right ventricle (DORV), as well as pulmonary stenosis, VSD, and right-sided aortic arch for which he underwent a first surgical…
Leggi di più
A RARE GUCH AND PULMONARY HYPERTENSION: A SHORT STORY
Anno:
2024
A 44-year-old woman presented to emergency department with dyspnea and anasarca. No past history of cardiologic diseases. Physical exam was notable for jugular turgor, hepatomegaly, rales and tachy-arrhythmic tones. Laboratory tests showed severe anemia (Hb 3.2 g/dl) and a severe mixed acidosis. ECG showed atrial fibrillation, 150/min. On echocardiogram…
Leggi di più
HIGH LEVELS OF SOLUBLE-SUPRESSION OF TUMORIGENICITY(s-ST2) PREDICT RIGHT VENTRICULAR/PULMONARY ARTERY UNCOUPLING WITH TAPSE/PAPs IN PATIENTS AFFECTED BY PULMONARY HYPERTENSION
Anno:
2024
Introduction: Pulmonary hypertension (PH) is a disease with an unfavorable prognosis, characterized by increasing in pulmonary resistence and right heart failure. One of the most important prognostic factors is the adaptation of the right ventricle to increased pressure overload, witch can be evaluated through tricuspid annular plane systolic excursion/systolic…
Leggi di più
Prognostic Value Mean Pulmonary Arterial Pressure and Pulmonary Vascular Resistance in Patients with Pulmonary Arterial Hypertension at Follow-Up
Anno:
2024
Background: Hemodynamic variables related to right ventricular (RV) function have consistently been associated with survival in pulmonary arterial hypertension (PAH). New PAH treatments, however, seems to improve RV coupling reducing RV afterload [e.g. mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR)], but without increasing cardiac output. The…
Leggi di più
EARLY DIAGNOSIS OF A RARE PULMONARY VASCULAR CONDITION: THE NEED FOR A HIGH INDEX OF SUSPICION, A GOOD NETWORK, AND THE RIGHT TOOLS
Anno:
2024
Pulmonary veno-occlusive disease (PVOD) is a rare and deadly form of pulmonary arterial hypertension (PAH), characterized by preferential venular involvement/obliteration. This leads to reduced diffusion capacity of the lung (DLCO), oxygen desaturation, and pathognomonic alterations at chest computed tomography (CT): mediastinal lymph node enlargement, centrilobular ground-glass opacities, smooth thickening…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram